Literature DB >> 33714276

Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.

Shuai Chen1, Ying Shen1, Yong-Hua Liu2, Yang Dai1, Zhi-Ming Wu1, Xiao-Qun Wang1, Chen-Die Yang1, Le-Ying Li1, Jing-Meng Liu1, Li-Ping Zhang2, Wei-Feng Shen1, Ri Ji3, Lin Lu4, Feng-Hua Ding5.   

Abstract

BACKGROUND: We investigated whether glycemic control affects the relation between endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus (T2DM).
METHODS: In 102 type 2 diabetic patients with stable angina, endothelial function was evaluated using brachial artery flow-mediated dilation (FMD) with high-resolution ultrasound, and significant stenosis of major epicardial coronary arteries (≥ 50% diameter narrowing) and degree of coronary atherosclerosis (Gensini score and SYNTAX score) were determined. The status of glycemic control was assessed by blood concentration of glycated hemoglobin (HbA1c).
RESULTS: The prevalence of significant coronary artery stenosis (67.9% vs. 37.0%, P = 0.002) and degree of coronary atherosclerosis (Gensini score: 48.99 ± 48.88 vs. 15.07 ± 21.03, P < 0.001; SYNTAX score: 15.88 ± 16.36 vs. 7.28 ± 10.54, P = 0.003) were higher and FMD was lower (6.03 ± 2.08% vs. 6.94 ± 2.20%, P = 0.036) in diabetic patients with poor glycemic control (HbA1c ≥ 7.0%; n = 56) compared to those with good glycemic control (HbA1c < 7.0%; n = 46). Multivariate regression analysis revealed that tertile of FMD was an independent determinant of presence of significant coronary artery stenosis (OR = 0.227 95% CI 0.056-0.915, P = 0.037), Gensini score (β =  - 0.470, P < 0.001) and SYNTAX score (β =  - 0.349, P = 0.004) in diabetic patients with poor glycemic control but not for those with good glycemic control (P > 0.05).
CONCLUSION: Poor glycemic control negatively influences the association of endothelial dysfunction and coronary artery disease in T2DM patients.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease; Flow-mediated dilation; Type 2 diabetes mellitus

Year:  2021        PMID: 33714276      PMCID: PMC7956110          DOI: 10.1186/s12933-021-01257-y

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  53 in total

1.  Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.

Authors:  A Pinto; A Tuttolomondo; D Di Raimondo; P Fernandez; G Licata
Journal:  Int Angiol       Date:  2006-09       Impact factor: 2.789

2.  Endothelial function in patients with and without diabetes mellitus with different degrees of coronary artery stenosis.

Authors:  Iana I Simova; Stefan V Denchev; Simeon I Dimitrov; Raia Ivanova
Journal:  J Clin Ultrasound       Date:  2009-01       Impact factor: 0.910

Review 3.  Evaluation of endothelial dysfunction: flow-mediated dilation.

Authors:  Hasan Korkmaz; Orhan Onalan
Journal:  Endothelium       Date:  2008 Jul-Aug

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 5.  Improvement of endothelial function by pitavastatin: a meta-analysis.

Authors:  Niki Katsiki; Željko Reiner; Eugenia Tedeschi Reiner; Khalid Al-Rasadi; Matteo Pirro; Dimitri P Mikhailidis; Amirhossein Sahebkar
Journal:  Expert Opin Pharmacother       Date:  2018-01-18       Impact factor: 3.889

6.  Endothelial dysfunction and cardiovascular outcome in asymptomatic patients with type 2 diabetes: A pilot study.

Authors:  Angelo Villano; Erica Mencarelli; Veronica Melita; Alessandro Rizzi; Priscilla Lamendola; Antonio De Vita; Laura Manfredonia; Salvatore Emanuele Ravenna; Dario Pitocco; Gaetano Antonio Lanza; Filippo Crea
Journal:  Diabetes Metab Res Rev       Date:  2019-11-19       Impact factor: 4.876

7.  Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.

Authors:  Thomas T van Sloten; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Thomas Unger; Miranda T Schram; Coen D A Stehouwer
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

8.  The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes.

Authors:  Yoshiaki Kubota; Masaaki Miyamoto; Gen Takagi; Takeshi Ikeda; Sonoko Kirinoki-Ichikawa; Kotoko Tanaka; Kyoichi Mizuno
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

Review 9.  Cardiovascular events, diabetes and guidelines: the virtue of simplicity.

Authors:  Ricardo J Esper; Roberto A Nordaby
Journal:  Cardiovasc Diabetol       Date:  2019-03-28       Impact factor: 9.951

Review 10.  Endothelial dysfunction in diabetes mellitus.

Authors:  Hadi A R Hadi; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2007
View more
  5 in total

Review 1.  Metabolic, structural and biochemical changes in diabetes and the development of heart failure.

Authors:  Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

2.  Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging.

Authors:  Meng-Ting Shen; Yuan Li; Ying-Kun Guo; Li Jiang; Yue Gao; Rui Shi; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2022-06-04       Impact factor: 8.949

3.  The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study.

Authors:  Yu Jiang; Yuan Li; Ke Shi; Jin Wang; Wen-Lei Qian; Wei-Feng Yan; Tong Pang; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2022-01-04       Impact factor: 9.951

Review 4.  Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis.

Authors:  Milijana Janjusevic; Alessandra Lucia Fluca; Giulia Gagno; Alessandro Pierri; Laura Padoan; Annamaria Sorrentino; Antonio Paolo Beltrami; Gianfranco Sinagra; Aneta Aleksova
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

5.  Relationship of the Circulating Endothelial Progenitor Cells to the Severity of a Coronary Artery Lesion in Unstable Angina.

Authors:  Cheng Xiao; Lixiang Liu; Xi Li; Xiaoan Yang; Hanxiong Liu
Journal:  Cardiol Res Pract       Date:  2022-07-05       Impact factor: 1.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.